1,504
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice

, , , , , , , , , , & show all
Pages 1-22 | Received 02 Aug 2017, Accepted 12 Nov 2017, Published online: 10 Jan 2018

References

  • OermannCMEnterovirusd68. A focused review and clinical highlights from the 2014 U.S. OutbreakAnn. Am. Thorac. Soc.201512 775 78110.1513/AnnalsATS.201412-592FR
  • StanwayGStructure, function and evolution of picornavirusesJ. Gen. Virol.199071Part 112483250110.1099/0022-1317-71-11-2483
  • LiuYShengJFokineAStructure and inhibition of EV-D68, a virus that causes respiratory illness in childrenScience2015347717410.1126/science.12619624307789
  • WeiWGuoHChangJICAM-5/telencephalin is a functional entry receptor for enterovirus D68Cell Host Microbe20162063164110.1016/j.chom.2016.09.013
  • LiuYShengJBaggenJSialic acid-dependent cell entry of human enterovirus D68Nat. Commun.2015610.1038/ncomms98654660200
  • BaggenJThibautHJStaringJEnterovirus D68 receptor requirements unveiled by haploid geneticsProc. Natl. Acad. Sci. USA20161131399140410.1073/pnas.15244981134747778
  • SchiebleJHFoxVLLennetteEHA probable new human picornavirus associated with respiratory diseasesAm. J. Epidemiol.19678529731010.1093/oxfordjournals.aje.a120693
  • KhetsurianiNLamonte-FowlkesAOberstSPallanschMAEnterovirus surveillance—United States, 1970-2005MMWR Surveill. Summ.200655120
  • Holm-HansenCCMidgleySEFischerTKGlobal emergence of enterovirus D68: a systematic reviewLancet Infect. Dis.201616e64e7510.1016/S1473-3099(15)00543-5
  • TokarzRFirthCMadhiSAWorldwide emergence of multiple clades of enterovirus 68J. Gen. Virol.2012931952195810.1099/vir.0.043935-03542132
  • SejvarJJLopezASCorteseMMAcute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillanceClin. Infect. Dis.20166373774510.1093/cid/ciw3725709818
  • MessacarKSchreinerTLMaloneyJAA cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USALancet20153851662167110.1016/S0140-6736(14)62457-0
  • AliabadiNMessacarKPastulaDMEnterovirus D68 infection in children with acute flaccid myelitis, Colorado, USA, 2014Emerg. Infect. Dis.2016221387139410.3201/eid2208.1519494982171
  • GreningerALNaccacheSNMessacarKA novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort studyLancet Infect. Dis.20151567168210.1016/S1473-3099(15)70093-9
  • MessacarKRobinsonCCPrettyKYuanJDominguezSRSurveillance for enterovirus D68 in colorado children reveals continued circulationJ. Clin. Virol.201792394110.1016/j.jcv.2017.05.009
  • StacpooleSRLMolyneuxABaumerDAcute segmental poliomyelitis-like flaccid paralysis in an adult in the UK, associated with enterovirus D68Pract. Neurol.20171729730110.1136/practneurol-2017-001609
  • TanWWangYZhaoYLuRPrevalence and genetic characterization of enterovirus D68 among children with severe acute respiratory infection in ChinaJ. Clin. Virol.201682S113S11310.1016/j.jcv.2016.08.226
  • RoldaoAMelladoMCCastilhoLRCarrondoMJAlvesPMVirus-like particles in vaccine developmentExpert Rev. Vaccin.201091149117610.1586/erv.10.115
  • KushnirNStreatfieldSJYusibovVVirus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical developmentVaccine201231588310.1016/j.vaccine.2012.10.083
  • LiuQYanKFengYA virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challengeVaccine2012306642664810.1016/j.vaccine.2012.08.071
  • KuZLiuQYeXA virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in miceVaccine2014324296430310.1016/j.vaccine.2014.06.025
  • ShenCKuZZhouYVirus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsVaccine2016344025403110.1016/j.vaccine.2016.06.028
  • ZhangCKuZLiuQHigh-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in miceVaccine2015332335234110.1016/j.vaccine.2015.03.034
  • ZhangCLiuQKuZCoxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in miceAntivir. Res.2016129475110.1016/j.antiviral.2016.02.011
  • ZhouYShenCZhangCYeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in miceAntivir. Res.201613216516910.1016/j.antiviral.2016.06.004
  • KuZShiJLiuQHuangZDevelopment of murine monoclonal antibodies with potent neutralization effects on enterovirus 71J. Virol. Methods201218619319710.1016/j.jviromet.2012.06.025
  • CaiYLiuQHuangXActive immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infectionVaccine2013312215222110.1016/j.vaccine.2013.03.007
  • ReedLJMuenchHA simple method of estimating fifty per cent endpointsAm. J. Epidemiol.19382749349710.1093/oxfordjournals.aje.a118408
  • LiuQDetection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteinsJ. Virol. Methods201117311512010.1016/j.jviromet.2011.01.016
  • KuZYeXHuangXNeutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment stepsPLoS One20138e5760110.1371/journal.pone.00576013579802
  • FengQHeYLuJVirus-like particles produced in Pichia pastoris induce protective immune responses against Coxsackievirus A16 in miceMed. Sci. Monit.2016223370338210.12659/MSM.9003805036384
  • LiHYHanJFQinCFChenRVirus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in miceVaccine2013313281328710.1016/j.vaccine.2013.05.019
  • ZhaoHLiHYHanJFVirus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in miceAppl. Microbiol. Biotechnol.201397104451045210.1007/s00253-013-5257-3
  • FooDGIdentification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptidesVirus Res.2007125616810.1016/j.virusres.2006.12.005
  • LiuCCChouAHLienSPIdentification and characterization of a cross-neutralization epitope of Enterovirus 71Vaccine2011294362437210.1016/j.vaccine.2011.04.010
  • JiangLFanRSunSA new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in miceVaccine2015336596660310.1016/j.vaccine.2015.10.104
  • ShiJHuangXLiuQHuangZIdentification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16Vaccine2013312130213610.1016/j.vaccine.2013.02.051
  • FioreLRidolfiBGenoveseDPoliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodiesJ. Virol.19977169056912191973
  • ChungYCHoMSWuJCImmunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeVaccine2008261855186210.1016/j.vaccine.2008.01.058